Adar1 Capital Management, LLC Prothena Corp Public LTD CO Call Options Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
212Shares Held
33.5MCall Options Held
848KPut Options Held
648K-
Black Rock Inc. New York, NY3.86MShares$29.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$16.9 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$9.61 Million1.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.18MShares$8.91 Million0.01% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $354M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...